VACCINATIONS AND THE RISK OF RELAPSE IN MULTIPLE SCLEROSIS

[1]  M. Maclure.  The case-crossover design: a method for studying transient effects on the risk of acute events. , 1991, American journal of epidemiology.

[2]  R. Tukkie,et al.  Bilateral optic neuritis with branch retinal artery occlusion associated with vaccination , 2005, Documenta Ophthalmologica.

[3]  P. Adeleine,et al.  Risk of cancer from azathioprine therapy in multiple sclerosis , 1996, Neurology.

[4]  W. Sibley,et al.  Swine influenza vaccination in patients with multiple sclerosis. , 1978, Archives of neurology.

[5]  R. Riikonen.  The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children , 1989, Acta neurologica Scandinavica.

[6]  M. Yahr,et al.  Relapsing encephalomyelitis following the use of influenza vaccine. , 1972, Archives of neurology.

[7]  M. Hutchinson,et al.  Rate of Pregnancy-Related Relapse in Multiple Sclerosis , 1998 .

[8]  P. Duclos.  Adverse events after hepatitis B vaccination. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[9]  J. Keyser,et al.  Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine , 1991, The Lancet.

[10]  S. Ellenberg,et al.  Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System. , 1996, The Pediatric Infectious Disease Journal.

[11]  L. Davis,et al.  Immune status of patients with multiple sclerosis , 1972, Neurology.

[12]  G. Aimard,et al.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.

[13]  F. Mérei,et al.  The possible role of vaccines and sera in the pathogenesis of multiple sclerosis. , 1961, World neurology.

[14]  A. Flanders,et al.  MR imaging in a case of postvaccination myelitis. , 1995, AJNR. American journal of neuroradiology.

[15]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[16]  C. Pozzilli,et al.  Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination , 1995, Journal of Neurology.

[17]  F. Retornaz,et al.  Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[18]  R. Knobler,et al.  A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis , 1997, Neurology.

[19]  W. Linssen,et al.  Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. , 2000, Neurology.

[20]  J. Keyser,et al.  Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis , 1998, Journal of the Neurological Sciences.

[21]  H. Miller,et al.  Multiple sclerosis and vaccination. , 1967, British medical journal.

[22]  S. Hadler,et al.  Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. , 1988, American journal of epidemiology.

[23]  C Confavreux,et al.  EDMUS, a European database for multiple sclerosis. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[24]  F. Zipp,et al.  No increase in demyelinating diseases after hepatitis B vaccination , 1999, Nature Medicine.

[25]  L. Kurland,et al.  Swine flu vaccine and multiple sclerosis. , 1984, JAMA.

[26]  W. Sibley,et al.  INFECTION AND IMMUNIZATION IN MULTIPLE SCLEROSIS * , 1965, Annals of the New York Academy of Sciences.

[27]  A. Sadovnick,et al.  School-based hepatitis B vaccination programme and adolescent multiple sclerosis , 2000, The Lancet.

[28]  B. McMahon,et al.  Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. , 1992, The American journal of medicine.

[29]  O. Eeg‐Olofsson,et al.  A PROSPECTIVE STUDY of PARAPARESES IN WESTERN SWEDEN , 1976, Acta neurologica Scandinavica.

[30]  J. Nadler.  Multiple sclerosis and hepatitis B vaccination. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  F. Trevisani,et al.  Transverse myelitis following hepatitis B vaccination. , 1993, Journal of hepatology.

[32]  O. Zwisler,et al.  Vaccination of patients with encephalomyelitis disseminata. , 1991, Vaccine.

[33]  G. Ellison,et al.  Swine influenza virus vaccination in patients with multiple sclerosis. , 1977, The Journal of infectious diseases.

[34]  Lublin Fd,et al.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .

[35]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[36]  G. Marchal,et al.  Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination. , 1990, European Neurology.

[37]  W. Sibley,et al.  Influenza vaccination in patients with multiple sclerosis. , 1976, JAMA.